CAT and fatty liver disease: CAT markedly reduced PA-induced intracellular lipid accumulation, and co-treatment with CC attenuated this effect, indicating that the protective effects of CAT against hepatic steatosis are mediated by the AMPK pathway (Figure 5C, 5D).